- Home
- KSS vs TARS Comparison
KSS vs TARS Comparison
Compare KSS & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSS
- TARS
- Stock Information
- Founded
- KSS 1962
- TARS 2016
- Country
- KSS United States
- TARS United States
- Employees
- KSS N/A
- TARS N/A
- Industry
- KSS Department/Specialty Retail Stores
- TARS Medicinal Chemicals and Botanical Products
- Sector
- KSS Consumer Discretionary
- TARS Health Care
- Exchange
- KSS Nasdaq
- TARS Nasdaq
- Market Cap
- KSS 2.1B
- TARS 1.8B
- IPO Year
- KSS 1992
- TARS 2020
- Fundamental
- Price
- KSS $18.02
- TARS $44.83
- Analyst Decision
- KSS Hold
- TARS Strong Buy
- Analyst Count
- KSS 8
- TARS 5
- Target Price
- KSS $21.38
- TARS $54.20
- AVG Volume (30 Days)
- KSS 6.5M
- TARS 1.1M
- Earning Date
- KSS 11-26-2024
- TARS 11-13-2024
- Dividend Yield
- KSS 11.11%
- TARS N/A
- EPS Growth
- KSS N/A
- TARS N/A
- EPS
- KSS 2.54
- TARS N/A
- Revenue
- KSS $17,124,000,000.00
- TARS $129,621,000.00
- Revenue This Year
- KSS N/A
- TARS $852.60
- Revenue Next Year
- KSS N/A
- TARS $74.21
- P/E Ratio
- KSS $7.08
- TARS N/A
- Revenue Growth
- KSS N/A
- TARS 801.96
- 52 Week Low
- KSS $17.41
- TARS $15.60
- 52 Week High
- KSS $29.60
- TARS $52.99
- Technical
- Relative Strength Index (RSI)
- KSS 43.89
- TARS 57.98
- Support Level
- KSS $18.02
- TARS $46.22
- Resistance Level
- KSS $18.73
- TARS $52.99
- Average True Range (ATR)
- KSS 0.73
- TARS 3.62
- MACD
- KSS 0.00
- TARS -0.33
- Stochastic Oscillator
- KSS 31.28
- TARS 42.09
About KSS Kohl's Corporation
Kohl's operates about 1,176 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 26% of its 2023 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.